Abstract:Background & aims We have previously reported on the potential pathogenic role of neutrophils in biliary atresia (BA). Herein, we aimed to delineate the role of CD177+ neutrophils in the pathogenesis of BA. Methods Immune cells from the livers of mice with rhesus rotavirus-induced BA were analysed. Single-cell RNA-sequencing was performed to specifically analyse Gr-1 + (Ly6C/Ly6G + ) cells in the liver. Gene expression profiles of CD177 + cells were analysed using the Smart-Seq RNA-sequencing method, and the pathogenesis of BA was examined in Cd177 -/- mice. Neutrophil extracellular trap (NET) inhibitors were used to determine the role of CD177 + cell-derived NETs in BA-associated bile duct damage, and a pilot clinical study evaluated the potential effects of N-acetylcysteine on NET release in BA. Results Increased levels of Gr-1 + cells were observed in the livers of mice with rhesus rotavirus-induced BA. RNA-sequencing analysis revealed that CD177 + cells were the main population of Gr-1 + cells and expressed elevated levels of both interferon-stimulated and neutrophil degranulation genes. Cd177 -/- BALB/c mice exhibited delayed disease onset and reduced morbidity and mortality. High numbers of mitochondria were detected in CD177 + cells derived from mice with BA; these cells were associated with increased levels of reactive oxygen species and increased NET formation, which induced the apoptosis of biliary epithelial cells in cocultures. In a pilot clinical study, the administration of N-acetylcysteine to patients with BA reduced CD177 + cell numbers and reactive oxygen species levels, indicating a potential beneficial effect. Conclusions Our data indicate that CD177 + cells play an important role in the initiation of BA pathogenesis via NET formation. Clinical trial registration The pilot study of N-acetylcysteine treatment in patients with BA was registered on the Chinese Clinical Trial Registry (ChiCTR2000040505). Lay summary Neutrophils (a type of innate immune cell, i.e. an immune cell that doesn't target a specific antigen) are thought to play a role in the development of biliary atresia (a rare but potentially lethal condition of the bile ducts that occurs in infants). Herein, we found that neutrophils expressing a particular protein (CD177) played an important role in bile duct damage by releasing a special structure (NET) that can trap and kill pathogens but that can also cause severe tissue damage. A pilot study in patients with biliary atresia showed that inhibiting NETs could have a beneficial effect.

Neurotensin Contributes to Cholestatic Liver Disease Potentially Modulating Matrix Metalloprotease-7

Neurotensin Contributes to Pediatric Intestinal Failure-Associated Liver Disease Via Regulating Intestinal Bile Acids Uptake.

Integrative single-cell and spatial transcriptomic analyses identify a pathogenic cholangiocyte niche and TNFRSF12A as therapeutic target for biliary atresia

MAPK signaling pathway induced LOX-1+ polymorphonuclear myeloid-derived suppressor cells in biliary atresia

Large-scale Proteomics Identifies MMP-7 As a Sentinel of Epithelial Injury and of Biliary Atresia.

Low Hepatic Artery Blood Flow Mediates NET Extravasation Through the Regulation of PIEZO1/SRC Signaling to Induce Biliary Complications after Liver Transplantation

CD177 + cells produce neutrophil extracellular traps that promote biliary atresia

Neurotrophic factors stimulate the activation of hepatic stellate cells in liver fibrosis

Neutrophil extracellular traps induce intrahepatic thrombotic tendency and liver damage in cholestatic liver disease

MicroRNA-21/PTEN/Akt Axis in the Fibrogenesis of Biliary Atresia

Metabolic regulation of cholestatic liver injury by D-2-hydroxyglutarate with the modulation of hepatic microenvironment and the mammalian target of rapamycin signaling

Liver Immune Profiling Reveals Pathogenesis and Therapeutics for Biliary Atresia

Correlation of Interleukin-33/ST2 Receptor and Liver Fibrosis Progression in Biliary Atresia Patients.

LncRNA MEG9 Promotes Inflammation and Liver Fibrosis Through S100A9 in Biliary Atresia

Long non-coding RNA H19 contributes to cholangiocyte proliferation and cholestatic liver fibrosis in biliary atresia.

Necroptosis of macrophage is a key pathological feature in biliary atresia via GDCA/S1PR2/ZBP1/p-MLKL axis

A Potential Profibrogenic Role of Biliary Epithelium-Derived Cardiotrophin-1 in Pediatric Cholestatic Liver Disease.

Progress in Biomarkers Related to Biliary Atresia

Mir-222 Overexpression May Contribute to Liver Fibrosis in Biliary Atresia by Targeting Ppp2r2a

Potential therapeutic target of EGF on bile duct ligation model and biliary atresia children